Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Ulevitch

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Nature Medicine|February 4, 1999
Endotoxin opens the Tollgates to innate immunityR J Ulevitch
Immunologic Research|June 14, 2000
Molecular mechanisms of innate immunityR J Ulevitch
Critical Care Medicine|July 11, 2001
New therapeutic targets revealed through investigations of innate immunityR J Ulevitch
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 1, 1991
Recognition of bacterial endotoxin in biologic systemsR J Ulevitch
Nature|November 5, 1999
Toll gates for pathogen selectionR J Ulevitch
Advances in Immunology|January 1, 1993
Recognition of bacterial endotoxins by receptor-dependent mechanismsR J Ulevitch
Immunochemistry|March 1, 1978
The preparation and characterization of a radioiodinated bacterial lipopolysaccharideR J Ulevitch
Biochimica Et Biophysica Acta|March 27, 2001
Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cellsT Chuang, R J Ulevitch
Shock (Augusta, Ga.)|April 3, 1998
Effect of recombinant interleukin-1beta on murine CD14 gene expression in vivoC Fearns, R J Ulevitch
Sheng Li Ke Xue Jin Zhan [Progress in Physiology]|January 21, 2003
[The signal transduction of cell activation by LPS: the studies from CD14 to p38 MAPK]Y Jiang, R J Ulevitch
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Nature Medicine|February 4, 1999
Endotoxin opens the Tollgates to innate immunityR J Ulevitch
Immunologic Research|June 14, 2000
Molecular mechanisms of innate immunityR J Ulevitch
Critical Care Medicine|July 11, 2001
New therapeutic targets revealed through investigations of innate immunityR J Ulevitch
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 1, 1991
Recognition of bacterial endotoxin in biologic systemsR J Ulevitch
Nature|November 5, 1999
Toll gates for pathogen selectionR J Ulevitch
Advances in Immunology|January 1, 1993
Recognition of bacterial endotoxins by receptor-dependent mechanismsR J Ulevitch
Immunochemistry|March 1, 1978
The preparation and characterization of a radioiodinated bacterial lipopolysaccharideR J Ulevitch
Biochimica Et Biophysica Acta|March 27, 2001
Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cellsT Chuang, R J Ulevitch
Shock (Augusta, Ga.)|April 3, 1998
Effect of recombinant interleukin-1beta on murine CD14 gene expression in vivoC Fearns, R J Ulevitch
Sheng Li Ke Xue Jin Zhan [Progress in Physiology]|January 21, 2003
[The signal transduction of cell activation by LPS: the studies from CD14 to p38 MAPK]Y Jiang, R J Ulevitch
Pageof 16